Skip to main content
SpringerLink
Log in

Pathology of Renal Cell Carcinoma

  • Chapter
  • First Online:
Renal Cell Carcinoma

Abstract

Renal cell carcinoma (RCC) is defined as a group of malignancies arising from the epithelium of the renal tubules (WHO) (Moch H, Humphrey P, Ulbright T, Reuter V, WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon, 2016). Although RCCs can be completely removed surgically in many cases, distant metastasis is common and may be observed even at an early stage of the disease. The classification of renal tumor had been traditionally determined according to the morphological features, such as the cytological appearance and architecture of tumor cells, and the application of immunohistochemistry, electron microscopy, and cytogenetics resulted in significant advances in the classification of RCC. Recently, many genetic aberrations of kidney tumors have been elucidated, and the genetic features have also become major criteria for the classification of some tumors. RCCs also occur in several inherited cancer syndromes, such as von Hippel-Lindau disease. Therefore, the current classification of kidney tumors is based on genetic difference as well as morphological characteristics (Moch H, Humphrey P, Ulbright T, Reuter V, WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon, 2016). Furthermore, some new disease entities have been proposed recently. This chapter aims to describe the histological, immunohistochemical, and genetic characteristics of RCCs that are useful for the differential diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moch H, Humphrey P, Ulbright T, Reuter V (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon

    Google Scholar 

  2. Murphy WMBJ, Farrow GM (1994) Atlas of tumour pathology. Tumours of the kidney, bladder, and related urinary structures, 3rd edn. AFIP, Washington, DC

    Google Scholar 

  3. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80(5):987–989

    Article  CAS  PubMed  Google Scholar 

  4. Brauch H, Weirich G, Brieger J, Glavac D, Rodl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Storkel S, Rotter M, Masera A, Gugeler N, Decker HJ (2000) VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res 60(7):1942–1948

    CAS  PubMed  Google Scholar 

  5. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA et al (1994) Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3(12):2169–2173

    Article  CAS  PubMed  Google Scholar 

  6. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM et al (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7(1):85–90. doi:10.1038/ng0594-85

    Article  CAS  PubMed  Google Scholar 

  7. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 91(21):9700–9704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317–1320

    Article  CAS  PubMed  Google Scholar 

  9. Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469(7331):539–542. doi:10.1038/nature09639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Presti JC Jr, Moch H, Gelb AB, Huynh D, Waldman FM (1998) Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization. J Urol 160(4):1557–1561

    Article  PubMed  Google Scholar 

  11. Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC (1991) Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51(5):1544–1552

    PubMed  Google Scholar 

  12. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD (1995) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269(5229):1402–1406

    Article  CAS  PubMed  Google Scholar 

  13. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441

    Article  PubMed  Google Scholar 

  14. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs. IARC Press, Lyon

    Google Scholar 

  15. Cheville JC, Blute ML, Zincke H, Lohse CM, Weaver AL (2001) Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J Urol 166(2):453–456

    Article  CAS  PubMed  Google Scholar 

  16. Ficarra V, Righetti R, Martignoni G, D’Amico A, Pilloni S, Rubilotta E, Malossini G, Mobilio G (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67(2):130–134

    Article  CAS  PubMed  Google Scholar 

  17. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663

    Article  CAS  PubMed  Google Scholar 

  18. Kuroda N, Tanaka A, Ohe C, Nagashima Y (2013) Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int 63(8):381–390. doi:10.1111/pin.12080

    Article  CAS  PubMed  Google Scholar 

  19. Kuroda N, Ohe C, Mikami S, Inoue K, Nagashima Y, Cohen RJ, Pan CC, Michal M, Hes O (2012) Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27(8):969–974

    PubMed  Google Scholar 

  20. Eble JN, Bonsib SM (1998) Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15(1):2–20

    CAS  PubMed  Google Scholar 

  21. del Vecchio MT, Lazzi S, Bruni A, Mangiavacchi P, Cevenini G, Luzi P (1998) DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival. Pathol Res Pract 194(5):325–333. doi:10.1016/S0344-0338(98)80056-3

    Article  PubMed  Google Scholar 

  22. Mydlo JH, Bard RH (1987) Analysis of papillary renal adenocarcinoma. Urology 30(6):529–534

    Article  CAS  PubMed  Google Scholar 

  23. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS (1997) Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21(6):621–635

    Article  CAS  PubMed  Google Scholar 

  24. Mancilla-Jimenez R, Stanley RJ, Blath RA (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38(6):2469–2480

    Article  CAS  PubMed  Google Scholar 

  25. Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol: an official journal of the United States and Canadian Academy of Pathology, Inc 10(6):537–544

    CAS  Google Scholar 

  26. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89(3):604–614

    Article  CAS  PubMed  Google Scholar 

  27. Renshaw AA, Richie JP (1999) Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. Am J Clin Pathol 111(4):539–543

    Article  CAS  PubMed  Google Scholar 

  28. Thoenes W, Storkel S, Rumpelt HJ, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variants – a report on 32 cases. J Pathol 155(4):277–287. doi:10.1002/path.1711550402

    Article  CAS  PubMed  Google Scholar 

  29. Memeo L, Jhang J, Assaad AM, McKiernan JM, Murty VV, Hibshoosh H, Tong GX, Mansukhani MM (2007) Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 127(2):225–229. doi:10.1309/9KWEA4W9Y94D1AEE

    Article  PubMed  Google Scholar 

  30. Srigley JR, Eble JN (1998) Collecting duct carcinoma of kidney. Semin Diagn Pathol 15(1):54–67

    CAS  PubMed  Google Scholar 

  31. Fleming S, Lewi HJ (1986) Collecting duct carcinoma of the kidney. Histopathology 10(11):1131–1141

    Article  CAS  PubMed  Google Scholar 

  32. Baer SC, Ro JY, Ordonez NG, Maiese RL, Loose JH, Grignon DG, Ayala AG (1993) Sarcomatoid collecting duct carcinoma: a clinicopathologic and immunohistochemical study of five cases. Hum Pathol 24(9):1017–1022

    Article  CAS  PubMed  Google Scholar 

  33. Kuroda N, Hes O, Michal M, Nemcova J, Gal V, Yamaguchi T, Kawada T, Imamura Y, Hayashi Y, Lee GH (2008) Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study. Histol Histopathol 23(12):1517–1523

    CAS  PubMed  Google Scholar 

  34. Kuroda N, Naroda T, Tamura M, Taguchi T, Tominaga A, Inoue K, Shuin T, Lee GH, Hes O, Michal M (2011) High-grade mucinous tubular and spindle cell carcinoma: comparative genomic hybridization study. Ann Diagn Pathol 15(6):472–475. doi:10.1016/j.anndiagpath.2010.08.003

    Article  PubMed  Google Scholar 

  35. Pillay N, Ramdial PK, Cooper K, Batuule D (2008) Mucinous tubular and spindle cell carcinoma with aggressive histomorphology – a sarcomatoid variant. Hum Pathol 39(6):966–969. doi:10.1016/j.humpath.2007.10.006

    Article  PubMed  Google Scholar 

  36. Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, Hafez N, Ladanyi M (2002) PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 26(12):1553–1566

    Article  PubMed  Google Scholar 

  37. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159(1):179–192. doi:10.1016/S0002-9440(10)61684-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27(6):750–761

    Article  PubMed  Google Scholar 

  39. Choyke PL (2000) Acquired cystic kidney disease. Eur Radiol 10(11):1716–1721

    Article  CAS  PubMed  Google Scholar 

  40. Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB, Cosimi AB, Tolkoff-Rubin N (2002) Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 61(6):2201–2209. doi:10.1046/j.1523-1755.2002.00374.x

    Article  PubMed  Google Scholar 

  41. Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153

    Article  PubMed  Google Scholar 

  42. Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, Zhang S, Brunelli M, Cheng L (2008) Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32(8):1239–1245. doi:10.1097/PAS.0b013e318164bcbb

    Article  PubMed  Google Scholar 

  43. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12(6):417–423. doi:10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K

    Article  CAS  PubMed  Google Scholar 

  44. Pavlovich CP, Schmidt LS, Phillips JL (2003) The genetic basis of renal cell carcinoma. Urol Clin North Am 30(3):437–454 vii

    Article  PubMed  Google Scholar 

  45. Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky I, Zhuang Z, Jeffers M, Vande Woude G, Neumann H, Walther M, Linehan WM, Zbar B (1998) Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58(8):1719–1722

    CAS  PubMed  Google Scholar 

  46. Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM (2000) Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol 163(2):431–433

    Article  CAS  PubMed  Google Scholar 

  47. Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF (1998) The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A 95(24):14417–14422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Alam NA, Bevan S, Churchman M, Barclay E, Barker K, Jaeger EE, Nelson HM, Healy E, Pembroke AC, Friedmann PS, Dalziel K, Calonje E, Anderson J, August PJ, Davies MG, Felix R, Munro CS, Murdoch M, Rendall J, Kennedy S, Leigh IM, Kelsell DP, Tomlinson IP, Houlston RS (2001) Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet 68(5):1264–1269. doi:10.1086/320124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, Barclay E, Calonje E, Manek S, Adams SJ, Bowers PW, Burrows NP, Charles-Holmes R, Cook LJ, Daly BM, Ford GP, Fuller LC, Hadfield-Jones SE, Hardwick N, Highet AS, Keefe M, MacDonald-Hull SP, Potts ED, Crone M, Wilkinson S, Camacho-Martinez F, Jablonska S, Ratnavel R, MacDonald A, Mann RJ, Grice K, Guillet G, Lewis-Jones MS, McGrath H, Seukeran DC, Morrison PJ, Fleming S, Rahman S, Kelsell D, Leigh I, Olpin S, Tomlinson IP (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12(11):1241–1252

    Article  CAS  PubMed  Google Scholar 

  50. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005) Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet 76(6):1023–1033. doi:10.1086/430842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, Mongiat-Artus P (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 58(5):701–710. doi:10.1016/j.eururo.2010.08.031

    Article  PubMed  Google Scholar 

  52. Davis CJ Jr, Mostofi FK, Sesterhenn IA (1995) Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19(1):1–11

    Article  PubMed  Google Scholar 

  53. Liu Q, Galli S, Srinivasan R, Linehan WM, Tsokos M, Merino MJ (2013) Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation. Am J Surg Pathol 37(3):368–374. doi:10.1097/PAS.0b013e3182770406

    Article  PubMed  Google Scholar 

  54. Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, Shah RB, Yang Y, Chuang ST, Lin F, Tretiakova MM, Kort EJ, Teh BT (2008) Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol 32(2):177–187. doi:10.1097/PAS.0b013e318150df1d

    Article  PubMed  Google Scholar 

  55. Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R (2009) Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol 33(12):1840–1849. doi:10.1097/PAS.0b013e3181be22d1

    Article  PubMed  Google Scholar 

  56. Amin MB, MacLennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A, Paner GP, Stovsky M, Young AN, Srigley JR, Cheville JC (2009) Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33(3):384–392. doi:10.1097/PAS.0b013e3181872d3f

    Article  PubMed  Google Scholar 

  57. Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118(18):4427–4436. doi:10.1002/cncr.27391

    Article  CAS  PubMed  Google Scholar 

  58. Marino-Enriquez A, Ou WB, Weldon CB, Fletcher JA, Perez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosom Cancer 50(3):146–153. doi:10.1002/gcc.20839

    Article  CAS  PubMed  Google Scholar 

  59. Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol: an official journal of the United States and Canadian Academy of Pathology, Inc 24(3):430–442. doi:10.1038/modpathol.2010.213

    Article  CAS  Google Scholar 

  60. Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ (2010) PAX8 (+)/p63 (−) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 34(7):965–969. doi:10.1097/PAS.0b013e3181dc5e8a

    Article  PubMed  PubMed Central  Google Scholar 

  61. Shen SS, Truong LD, Scarpelli M, Lopez-Beltran A (2012) Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med 136(4):410–417. doi:10.5858/arpa.2011-0472-RA

    Article  PubMed  Google Scholar 

  62. Skinnider BF, Amin MB (2005) An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 22(1):51–68

    Article  PubMed  Google Scholar 

  63. Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2005) Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. Histol Histopathol 20(1):221–224

    CAS  PubMed  Google Scholar 

  64. Mikami S, Oya M, Mukai M (2008) Angiomyolipoma with epithelial cysts of the kidney in a man. Pathol Int 58(10):664–667. doi:10.1111/j.1440-1827.2008.02287.x

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan

    Shuji Mikami

  2. Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan

    Naoto Kuroda

  3. Department of Surgical Pathology, Tokyo Women’s Medical University, Tokyo, Japan

    Yoji Nagashima

Authors
  1. Shuji Mikami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoto Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoji Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuji Mikami .

Editor information

Editors and Affiliations

  1. Department of Urology, Keio University School of Medicine, Tokyo, Japan

    Mototsugu Oya

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Mikami, S., Kuroda, N., Nagashima, Y. (2017). Pathology of Renal Cell Carcinoma. In: Oya, M. (eds) Renal Cell Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55531-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55531-5_4

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55530-8

  • Online ISBN: 978-4-431-55531-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation